Literature DB >> 16237051

Cutting edge: early IFN-gamma signaling directly enhances primary antiviral CD4+ T cell responses.

Jason K Whitmire1, Nicola Benning, J Lindsay Whitton.   

Abstract

IFN-gamma drives CD4+ T cell differentiation toward the Th1 phenotype (Th1) and suppresses Th2 development. Current evidence indicates that IFN-gamma inhibits T cell proliferation and decreases T cell survival. In contrast to the above, we show here that antiviral CD4+ T cell generation after infection is reduced in the absence of IFN-gamma signals. The deficient expansion of cells was not due to perturbations in T cell sensitivity to peptide or to altered migratory patterns through nonlymphoid tissues. Instead, IFN-gamma enhanced early antiviral CD4 responses largely through direct signals into these cells. Our data challenge prevailing dogma and have implications for how the sizes of the CD8+ and CD4+ T cell responses are established.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237051     DOI: 10.4049/jimmunol.175.9.5624

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Authors:  Luiz Felipe Domingues Passero; Ana Kely Carvalho; Maria Luiza A C Bordon; Alexis Bonfim-Melo; Marcos Hikari Toyama; Carlos Eduardo Pereira Corbett; Márcia Dalastra Laurenti
Journal:  Inflamm Res       Date:  2011-12-14       Impact factor: 4.575

2.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.

Authors:  Stephen J Crocker; Jason K Whitmire; Ricardo F Frausto; Parntip Chertboonmuang; Paul D Soloway; J Lindsay Whitton; Iain L Campbell
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 4.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.

Authors:  Susan M Kaech; E John Wherry
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

5.  CD4 memory T cells divide poorly in response to antigen because of their cytokine profile.

Authors:  Megan K L MacLeod; Amy McKee; Frances Crawford; Janice White; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-11       Impact factor: 11.205

6.  Increasing the CD4+ T cell precursor frequency leads to competition for IFN-gamma thereby degrading memory cell quantity and quality.

Authors:  Jason K Whitmire; Nicola Benning; Boreth Eam; J Lindsay Whitton
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.

Authors:  Adora A Lin; Pulak K Tripathi; Allyson Sholl; Michael B Jordan; David A Hildeman
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Influenza virus-specific immunological memory is enhanced by repeated social defeat.

Authors:  Jacqueline W Mays; Michael T Bailey; John T Hunzeker; Nicole D Powell; Tracey Papenfuss; Erik A Karlsson; David A Padgett; John F Sheridan
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

9.  Immune effectors required for hepatitis B virus clearance.

Authors:  Priscilla L Yang; Alana Althage; Josan Chung; Holly Maier; Stefan Wieland; Masanori Isogawa; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Authors:  Courtney Dow; Carla Oseroff; Bjoern Peters; Courtney Nance-Sotelo; John Sidney; Michael Buchmeier; Alessandro Sette; Bianca R Mothé
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.